Marquette Asset Management’s Charles River Laboratories CRL Stock Holding History

Marquette Asset Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.59K	Hold	7	–	–	﹤0.01%	657
2026 Q1	$1.21K	Buy	+7	New	+$1.3K	﹤0.01%	649
2024 Q1	–	Sell	-497	Closed	-$117K	–	203
2023 Q4	$117K	Hold	497	–	–	0.02%	99
2023 Q3	$97.4K	Hold	497	–	–	0.02%	104
2023 Q2	$104K	Hold	497	–	–	0.03%	115
2023 Q1	$100K	Hold	497	–	–	0.03%	110
2022 Q4	$108K	Hold	497	–	–	0.03%	106
2022 Q3	$98K	Hold	497	–	–	0.03%	106
2022 Q2	$106K	Hold	497	–	–	0.03%	125
2022 Q1	$141K	Hold	497	–	–	0.03%	119
2021 Q4	$187K	Hold	497	–	–	0.04%	105
2021 Q3	$205K	Hold	497	–	–	0.05%	94
2021 Q2	$184K	Hold	497	–	–	0.04%	97
2021 Q1	$144K	Hold	497	–	–	0.03%	110
2020 Q4	$124K	Hold	497	–	–	0.03%	114
2020 Q3	$113K	Hold	497	–	–	0.03%	98
2020 Q2	$87K	Hold	497	–	–	0.03%	120
2020 Q1	$63K	Hold	497	–	–	0.03%	138
2019 Q4	$76K	Hold	497	–	–	0.02%	117
2019 Q3	$66K	Hold	497	–	–	0.02%	131
2019 Q2	$71K	Hold	497	–	–	0.02%	128
2019 Q1	$72K	Buy	+497	New	+$65.3K	0.02%	125

Other funds holding CRL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Marquette Asset Management's CRL Position: Q2 2026 in Review

Marquette Asset Management held its Charles River Laboratories (CRL) position steady in Q2 2026 at 7 shares worth $1.59K. The position accounts for ﹤0.01% of the portfolio, ranked #657.

Marquette Asset Management first reported a position in CRL in Q1 2019 and has held it in 22 quarters since. The position peaked at $205K in Q3 2021. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

Marquette Asset Management held 7 shares of Charles River Laboratories worth $1.59K as of Q2 2026.
Marquette Asset Management left its Charles River Laboratories share count unchanged in Q2 2026.
Charles River Laboratories made up ﹤0.01% of Marquette Asset Management's portfolio in Q2 2026, its #657 holding.
Marquette Asset Management first reported a position in Charles River Laboratories in Q1 2019 and has held it in 22 quarters since.
Marquette Asset Management's Charles River Laboratories position peaked at $205K in Q3 2021.
570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Marquette Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.